{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:09:09Z","timestamp":1788322149469,"version":"build-2803163510"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Bloodstream infections (BSIs) due to vancomycin-resistant Enterococcus spp. (VRE) are considered a predictor of mortality among frail patients. The aim of this study was to evaluate the risk factors associated with 30 day mortality and relapse of infection in enterococcal BSI caused by VRE and to evaluate the impact of antibiotic regimens in targeted therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective study of consecutive hospitalized patients in six teaching hospitals from August 2016 to August 2022 in Italy. All adult patients with a documented VRE BSI were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We enrolled 517 consecutive hospitalized patients with VRE BSI; of these BSIs 496 (96.5%) were caused by Enterococcus faecium and 26 (5.1%) by Enterococcus faecalis. The most frequently used antibiotics as backbone were linezolid (48.1%) and daptomycin (43.7%). Overall, the 30 day mortality was 32.1%. Upon Cox regression analysis, the risk factor independently associated with 30 day mortality was Charlson comorbidity index &amp;gt;3 points (P\u200a&amp;lt;\u200a0.001), whereas a Pitt score &amp;lt;4 points (P\u200a=\u200a0.031), surgery for source control of infection (P\u200a=\u200a0.016) and time to targeted therapy &amp;lt;24\u2005h (P\u200a=\u200a0.006) were associated with survival. After propensity score adjustment, a daptomycin-based regimen (P\u200a=\u200a0.003) was associated with 30 day survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>VRE BSI is an important cause of mortality in frail\/critically ill patients. Our data highlighted the role of daptomycin as backbone agent for the treatment of enterococcal BSI caused by vancomycin-resistant strains.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaf055","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T08:20:43Z","timestamp":1740471643000},"page":"1241-1247","source":"Crossref","is-referenced-by-count":11,"title":["Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience"],"prefix":"10.1093","volume":"80","author":[{"given":"Francesca","family":"Serapide","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, \u2018Magna Graecia\u2019 University of Catanzaro , Catanzaro ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Serraino","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, \u2018Magna Graecia\u2019 University of Catanzaro , Catanzaro ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Spadafora","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome , Latina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bernardi","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome , Latina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Brucci","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Cattardico","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Corcione","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin , Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"De Benedetto","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin , Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Del Monte","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Limongelli","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Roberto","family":"Giacobbe","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Graziano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Infectious and Tropical Diseases Unit, University of Insubria-ASST-Sette Laghi , Varese ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Meschiari","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Mornese","family":"Pinna","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin , Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Peghin","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Infectious and Tropical Diseases Unit, University of Insubria-ASST-Sette Laghi , Varese ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Tiseo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Pisana, University of Pisa , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vena","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Romeo","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, \u2018Magna Graecia\u2019 University of Catanzaro , Catanzaro ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Sarto","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome , Latina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-8510","authenticated-orcid":false,"given":"Giuseppe","family":"Biondi-Zoccai","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome , Latina ,","place":["Italy"]},{"name":"Maria Cecilia Hospital, GVM Care & Research , Cotignola ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8338-0130","authenticated-orcid":false,"given":"Francesco Giuseppe","family":"De Rosa","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin , Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-8796","authenticated-orcid":false,"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Pisana, University of Pisa , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-5061","authenticated-orcid":false,"given":"Paolo Antonio","family":"Grossi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Infectious and Tropical Diseases Unit, University of Insubria-ASST-Sette Laghi , Varese ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Infectious and Tropical Disease Unit, \u2018Magna Graecia\u2019 University of Catanzaro , Catanzaro ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"2025050205521649400_dkaf055-B1","doi-asserted-by":"publisher","first-page":"e0005922","DOI":"10.1128\/cmr.00059-22","article-title":"Therapeutics for vancomycin-resistant enterococcal bloodstream infections","volume":"36","author":"Cairns","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"2025050205521649400_dkaf055-B2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.cmi.2020.10.029","article-title":"How do I manage a patient with enterococcal bacteraemia?","volume":"27","author":"Rosselli Del Turco","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025050205521649400_dkaf055-B3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.33321\/cdi.2020.44.72","article-title":"Australian group on antimicrobial resistance (AGAR) Australian enterococcal sepsis outcome programme (AESOP) annual report 2019","author":"Coombs","year":"2020","journal-title":"Commun Dis Intell (2018)"},{"key":"2025050205521649400_dkaf055-B4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13756-020-00737-2","article-title":"One health in hospitals: how understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections","volume":"9","author":"Dalton","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"2025050205521649400_dkaf055-B5","volume-title":"Responding to the Threat of Antimicrobial Resistance, Australia\u2019s First National Antimicrobial Resistance Strategy 2015\u20132019","author":"Australian Government","year":"2015"},{"key":"2025050205521649400_dkaf055-B6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025050205521649400_dkaf055-B7","doi-asserted-by":"publisher","first-page":"ofz473","DOI":"10.1093\/ofid\/ofz473","article-title":"Impact on mortality of a bundle for the management of enterococcal bloodstream infection","volume":"6","author":"Bartoletti","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025050205521649400_dkaf055-B8","doi-asserted-by":"publisher","first-page":"11925","DOI":"10.3390\/ijms231911925","article-title":"Time to effective therapy is an important determinant of survival in bloodstream infections caused by vancomycin-resistant Enterococcus spp","volume":"23","author":"Russo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025050205521649400_dkaf055-B9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1586\/14787210.2015.1001839","article-title":"Therapeutic options for vancomycin-resistant enterococcal bacteremia","volume":"13","author":"Barber","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025050205521649400_dkaf055-B10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jgar.2019.10.008","article-title":"Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis","volume":"21","author":"Shi","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"2025050205521649400_dkaf055-B11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1469-0691.2006.01455.x","article-title":"EUCAST technical note on daptomycin","volume":"12","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"2025050205521649400_dkaf055-B12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1586\/14787210.2.1.51","article-title":"A review of linezolid: the first oxazolidinone antibiotic","volume":"2","author":"Stevens","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025050205521649400_dkaf055-B13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.cmi.2020.04.027","article-title":"Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper","volume":"26","author":"Turnidge","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2025050205521649400_dkaf055-B14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1017\/ice.2019.15","article-title":"A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization","volume":"40","author":"Hughes","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025050205521649400_dkaf055-B15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.micpath.2016.05.019","article-title":"Molecular epidemiology of vancomycin resistant enterococci in a tertiary care hospital in Saudi Arabia","volume":"97","author":"Somily","year":"2016","journal-title":"Microb Pathog"},{"key":"2025050205521649400_dkaf055-B16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jhin.2023.09.008","article-title":"Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis","volume":"141","author":"Eichel","year":"2023","journal-title":"J Hosp Infect"},{"key":"2025050205521649400_dkaf055-B17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijid.2014.02.012","article-title":"Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study","volume":"26","author":"Billington","year":"2014","journal-title":"Int J Infect Dis"},{"key":"2025050205521649400_dkaf055-B18","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1111\/1469-0691.12132","article-title":"Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization","volume":"19","author":"Cheah","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"2025050205521649400_dkaf055-B19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jgar.2020.12.005","article-title":"Risk factors and outcomes associated with vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: a 10-year study in a tertiary-care centre in Mexico City","volume":"24","author":"L\u00f3pez-Luis","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"2025050205521649400_dkaf055-B20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/antibiotics13070601","article-title":"Risk factors for 30-day mortality in nosocomial enterococcal bloodstream infections","volume":"13","author":"Zerbato","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"2025050205521649400_dkaf055-B21","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12879-022-07864-8","article-title":"Risk factors and outcomes associated with persistent vancomycin resistant enterococcal bacteremia","volume":"22","author":"Fox","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025050205521649400_dkaf055-B22","doi-asserted-by":"publisher","first-page":"ofab616","DOI":"10.1093\/ofid\/ofab616","article-title":"Contemporary clinical and molecular epidemiology of vancomycin-resistant enterococcal bacteremia: a prospective multicenter cohort study (VENOUS I)","volume":"9","author":"Contreras","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025050205521649400_dkaf055-B23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ijantimicag.2019.08.011","article-title":"Daptomycin-containing regimens for treatment of gram-positive endocarditis","volume":"54","author":"Russo","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2025050205521649400_dkaf055-B24","doi-asserted-by":"publisher","first-page":"106432","DOI":"10.1016\/j.ijantimicag.2021.106432","article-title":"Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series","volume":"58","author":"Russo","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"2025050205521649400_dkaf055-B25","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/jac\/dky072","article-title":"Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review","volume":"73","author":"Foolad","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025050205521649400_dkaf055-B26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/cid\/civ444","article-title":"Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of Veterans Affairs patients","volume":"61","author":"Britt","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025050205521649400_dkaf055-B27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40121-022-00754-1","article-title":"The combination of daptomycin with fosfomycin is more effective than daptomycin alone in reducing mortality of vancomycin-resistant enterococcal bloodstream infections: a retrospective, comparative cohort study","volume":"12","author":"Tseng","year":"2023","journal-title":"Infect Dis Ther"},{"key":"2025050205521649400_dkaf055-B28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12941-017-0199-8","article-title":"The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025050205521649400_dkaf055-B29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40121-019-00261-w","article-title":"Should high-dose daptomycin be an alternative treatment regimen for enterococcal endocarditis?","volume":"8","author":"Peghin","year":"2019","journal-title":"Infect Dis Ther"},{"key":"2025050205521649400_dkaf055-B30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jiac.2015.02.012","article-title":"Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature","volume":"21","author":"Falcone","year":"2015","journal-title":"J Infect Chemother"},{"key":"2025050205521649400_dkaf055-B31","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/antibiotics9120889","article-title":"Efficacy of daptomycin-containing regimen for treatment of staphylococcal or enterococcal vertebral osteomyelitis: a prospective clinical experience","volume":"9","author":"Russo","year":"2020","journal-title":"Antibiotics (Basel)"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/5\/1241\/62163302\/dkaf055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/5\/1241\/62163302\/dkaf055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T09:52:23Z","timestamp":1746179543000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/5\/1241\/8041834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,2,25]]},"published-print":{"date-parts":[[2025,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf055","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,2,25]]}}}